Angiolymphoid hyperplasia with eosinophilia (AHE) has been known by a variety of different names, such as epithelioid hemangioma, pseudopyogenic granuloma
, inflammatory angiomatous nodule, papular angioplasia, subcutaneous angioblastic lymphoid hyperplasia with eosinophilia and lymphofolliculosis, intravenous atypical vascular proliferation and histiocytoid hemangioma.
Although other names have been given to ALHE/EH, such as histiocytoid hemangioma, angiomatous nodule, pseudopyogenic granuloma
, and inflammatory angiomatous nodule, (3,4) angiolymphoid hyperplasia with eosinophilia and epithelioid hemangioma remain the current unanimously accepted terms for this entity.
In the literature various terms have been used by different authors to describe this lesion, including angioblastic hyperplasia with eosinophilia (ALHE), nodular angioblastic lymphoid hyperplasia with eosinophilia, lymphofolliculosis, histiocytoid hemangioma pseudopyogenic granuloma
, and atypical pyogenic granuloma.